180 related articles for article (PubMed ID: 29634658)
1. Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma.
Sun M; Zhang G; Guo J; Hao S; Wang Z; Fan G
Nucl Med Commun; 2018 Jun; 39(6):564-571. PubMed ID: 29634658
[TBL] [Abstract][Full Text] [Related]
2. Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers.
Takeuchi S; Rohren EM; Abdel-Wahab R; Xiao L; Morris JS; Macapinlac HA; Hassan MM; Kaseb AO
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):969-978. PubMed ID: 27942837
[TBL] [Abstract][Full Text] [Related]
3.
Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M
J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
Hyun SH; Eo JS; Lee JW; Choi JY; Lee KH; Na SJ; Hong IK; Oh JK; Chung YA; Song BI; Kim TS; Kim KS; Moon DH; Yun M
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1638-45. PubMed ID: 26936852
[TBL] [Abstract][Full Text] [Related]
5.
Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
[TBL] [Abstract][Full Text] [Related]
6. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
Cho E; Jun CH; Kim BS; Son DJ; Choi WS; Choi SK
Turk J Gastroenterol; 2015 Jul; 26(4):344-50. PubMed ID: 26039005
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
10. Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization.
Hwang SH; Hong HS; Kim D; Kim GM; Lee HW; Lee M; Kim DY; Park MA; Yun M
Clin Nucl Med; 2022 Jun; 47(6):e437-e443. PubMed ID: 35384891
[TBL] [Abstract][Full Text] [Related]
11.
Sung PS; Park HL; Yang K; Hwang S; Song MJ; Jang JW; Choi JY; Yoon SK; Yoo IR; Bae SH
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):384-391. PubMed ID: 29124280
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
13. Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.
Kim MJ; Kim YS; Cho YH; Jang HY; Song JY; Lee SH; Jeong SW; Kim SG; Jang JY; Kim HS; Kim BS; Lee WH; Park JM; Lee JM; Lee MH; Choi DL
Korean J Intern Med; 2015 May; 30(3):308-15. PubMed ID: 25995661
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
Song MJ; Bae SH; Yoo IeR; Park CH; Jang JW; Chun HJ; Choi BG; Lee HG; Choi JY; Yoon SK
World J Gastroenterol; 2012 Jul; 18(25):3215-22. PubMed ID: 22783045
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.
Detry O; Govaerts L; Deroover A; Vandermeulen M; Meurisse N; Malenga S; Bletard N; Mbendi C; Lamproye A; Honoré P; Meunier P; Delwaide J; Hustinx R
World J Gastroenterol; 2015 Mar; 21(10):3049-54. PubMed ID: 25780305
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma.
Lee JW; Hwang SH; Kim DY; Han KH; Yun M
Clin Nucl Med; 2017 Jan; 42(1):e35-e40. PubMed ID: 27775940
[TBL] [Abstract][Full Text] [Related]
17. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
Pant V; Sen IB; Soin AS
Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of
Lim CH; Moon SH; Cho YS; Choi JY; Lee KH; Hyun SH
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1705-1712. PubMed ID: 31049603
[TBL] [Abstract][Full Text] [Related]
19. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
Sun Y; Lu P; Yu L
Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
[TBL] [Abstract][Full Text] [Related]
20. Does 18F-FDG positron emission tomography-computed tomography have a role in initial staging of hepatocellular carcinoma?
Cho Y; Lee DH; Lee YB; Lee M; Yoo JJ; Choi WM; Cho YY; Paeng JC; Kang KW; Chung JK; Yu SJ; Lee JH; Yoon JH; Lee HS; Kim YJ
PLoS One; 2014; 9(8):e105679. PubMed ID: 25153834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]